malignant brain tumors
Conditions
Interventions
Observation group:None
Sponsors
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Aged between 18 and 80 years old (both 18 and 80 years old are included). 2.Patients whose pathology indicates a malignant brain tumor. 3.Both genders are eligible. 4.The patient himself/herself or the family member who serves as the guardian signs the informed consent form for the study.
Exclusion criteria
Exclusion criteria: 1. Patients with intracranial space-occupying lesions who have no pathological diagnosis or whose diagnosis is unclear. 2. Family members or patients refuse to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The survival rate of organoid cell culture;Overall Survival;Progression-Free Survival, PFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of change in tumor volume,;Neurological function scores;Tumor biomarkers; | — |
Countries
China
Contacts
Public ContactYifeng Miao
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Outcome results
None listed